By Chris Wack
Helius Medical Technologies shares were up 10% to $6.25 after the company said it has partnered with Lovell Government Services, an SBA-certified Service Disabled Veteran Owned Small Business, to make its portable neuromodulation stimulator device available to federal healthcare systems.
The stock hit its 52-week low of $4.29 on Feb. 28, and is down 49% in the past 12 months.
The portable neuromodulation stimulator is allowed in the U.S. for use as a short-term treatment of gait deficit in adults with mild to moderate symptoms from multiple sclerosis when used in conjunction with physical therapy.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
April 03, 2024 12:49 ET (16:49 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments